Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P95
Near historical high
vs 2Y Ago
7.7x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 34.63% |
| Q3 2025 | 18.97% |
| Q2 2025 | -2.75% |
| Q1 2025 | -14.40% |
| Q4 2024 | 0.23% |
| Q3 2024 | -0.45% |
| Q2 2024 | -14.74% |
| Q1 2024 | -5.82% |
| Q4 2023 | 4.51% |
| Q3 2023 | 11.37% |
| Q2 2023 | -1.29% |
| Q1 2023 | -28.32% |
| Q4 2022 | -4.44% |
| Q3 2022 | 13.88% |
| Q2 2022 | 5.70% |
| Q1 2022 | -16.25% |
| Q4 2021 | -36.12% |
| Q3 2021 | -1.58% |
| Q2 2021 | -26.59% |
| Q1 2021 | 16.24% |
| Q4 2020 | -48.91% |
| Q3 2020 | -6.36% |
| Q2 2020 | 0.53% |
| Q1 2020 | 3.85% |
| Q4 2019 | -1.94% |
| Q3 2019 | 0.30% |
| Q2 2019 | -6.51% |
| Q1 2019 | 3.46% |
| Q4 2018 | -6.45% |
| Q3 2018 | 13.16% |
| Q2 2018 | 4.63% |
| Q1 2018 | -23.02% |
| Q4 2017 | 34.73% |
| Q3 2017 | 1.54% |
| Q2 2017 | 41.85% |
| Q1 2017 | -3.51% |
| Q4 2016 | 1.44% |
| Q3 2016 | 0.56% |
| Q2 2016 | 4.57% |
| Q1 2016 | -41.62% |